Health
Moderna COVID-19 vaccine well-tolerated, generates immune response in older adults: Study – The Indian Express
The study, published in the New England Journal of Medicine, noted that the experimental vaccine, mRNA-1273, was well-tolerated by the older trial participants,…
By: AP | Boston |
Updated: September 30, 2020 7:40:28 pm
According to the researchers from NIAID, older adults are more vulnerable to complications of COVID-19, and are an important population for vaccination. (AP/File)Results from the Phase 1 trial of an investigational COVID-19 vaccine co-developed by researchers at the US National Institute of Allergy and Infectious Diseases (NIAID), and the American biotech company Moderna have shown that it is well-tolerated and generates a strong immune…
-
Business21 hours agoIs Warren Buffett’s Berkshire Hathaway the smartest investment you can make today?
-
Noosa News7 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
General21 hours agoTop chess player Magnus Carlsen forced into draw in historic game against over 134,000 people
-
General21 hours agoTaiwan’s President Lai Ching-te calls for peace and dialogue with China while also calling for defence boosts